{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:40:38Z","timestamp":1789987238552,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T00:00:00Z","timestamp":1521849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003180","name":"Academic Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003180","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s11882-018-0776-8","type":"journal-article","created":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T06:04:07Z","timestamp":1521871447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Precision Medicine in Chronic Rhinosinusitis with Nasal Polyps"],"prefix":"10.1007","volume":"18","author":[{"given":"Klementina","family":"Avdeeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wytske","family":"Fokkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,24]]},"reference":[{"key":"776_CR1","unstructured":"Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinology Supplement. 2012 (23):3 p preceding table of contents, 1\u2013298."},{"issue":"9","key":"776_CR2","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","volume":"66","author":"D Hastan","year":"2011","unstructured":"Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J, Bockelbrink A, et al. Chronic rhinosinusitis in Europe\u2014an underestimated disease. A GA(2)LEN study. Allergy. 2011;66(9):1216\u201323.","journal-title":"Allergy"},{"issue":"4","key":"776_CR3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4193\/Rhin15.157","volume":"54","author":"JH Kim","year":"2016","unstructured":"Kim JH, Cho C, Lee EJ, Suh YS, Choi BI, Kim KS. Prevalence and risk factors of chronic rhinosinusitis in South Korea according to diagnostic criteria. Rhinology. 2016;54(4):329\u201335.","journal-title":"Rhinology"},{"issue":"2","key":"776_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/all.13042","volume":"72","author":"AG Hirsch","year":"2017","unstructured":"Hirsch AG, Stewart WF, Sundaresan AS, Young AJ, Kennedy TL, Scott Greene J, et al. Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample. Allergy. 2017;72(2):274\u201381.","journal-title":"Allergy"},{"issue":"4","key":"776_CR5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4193\/Rhin15.361","volume":"54","author":"S Erskine","year":"2016","unstructured":"Erskine S, Hopkins C, Kumar N, Wilson J, Clark A, Robertson A, et al. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes. Rhinology. 2016;54(4):311\u20135.","journal-title":"Rhinology"},{"issue":"4","key":"776_CR6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4193\/Rhin16.211","volume":"54","author":"LP Hoehle","year":"2016","unstructured":"Hoehle LP, Phillips KM, Bergmark RW, Caradonna DS, Gray ST, Sedaghat AR. Symptoms of chronic rhinosinusitis differentially impact general health-related quality of life. Rhinology. 2016;54(4):316\u201322.","journal-title":"Rhinology"},{"issue":"3","key":"776_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11882-010-0175-2","volume":"11","author":"L Rudmik","year":"2011","unstructured":"Rudmik L, Smith TL. Quality of life in patients with chronic rhinosinusitis. Curr Allergy Asthma Rep. 2011;11(3):247\u201352.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"776_CR8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4193\/Rhin16.126","volume":"55","author":"P Sahlstrand-Johnson","year":"2017","unstructured":"Sahlstrand-Johnson P, Hopkins C, Ohlsson B, Ahlner-Elmqvist M. The effect of endoscopic sinus surgery on quality of life and absenteeism in patients with chronic rhinosinuitis\u2014a multi-centre study. Rhinology. 2017;55(3):251\u201361.","journal-title":"Rhinology"},{"issue":"7","key":"776_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/000348941112000701","volume":"120","author":"N Bhattacharyya","year":"2011","unstructured":"Bhattacharyya N. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Ann Otology, Rhinol Laryngol. 2011;120(7):423\u20137.","journal-title":"Ann Otology, Rhinol Laryngol"},{"issue":"7","key":"776_CR10","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/lary.25180","volume":"125","author":"KA Smith","year":"2015","unstructured":"Smith KA, Orlandi RR, Rudmik L. Cost of adult chronic rhinosinusitis: a systematic review. Laryngoscope. 2015;125(7):1547\u201356.","journal-title":"Laryngoscope"},{"issue":"2","key":"776_CR11","first-page":"69","volume":"40","author":"M Agthoven van","year":"2002","unstructured":"van Agthoven M, Uyl-de Groot CA, Fokkens WJ, van de Merwe JP, Busschbach JJ. Cost analysis of regular and filgrastim treatment in patients with refractory chronic rhinosinusitis. Rhinology. 2002;40(2):69\u201374.","journal-title":"Rhinology"},{"issue":"4","key":"776_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11882-017-0690-5","volume":"17","author":"L Rudmik","year":"2017","unstructured":"Rudmik L. Economics of chronic rhinosinusitis. Curr Allergy Asthma Rep. 2017;17(4):20.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"7","key":"776_CR13","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/all.12629","volume":"70","author":"DR Morales","year":"2015","unstructured":"Morales DR, Guthrie B, Lipworth BJ, Jackson C, Donnan PT, Santiago VH. NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity. Allergy. 2015;70(7):828\u201335.","journal-title":"Allergy"},{"issue":"4","key":"776_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jaip.2016.03.010","volume":"4","author":"AE Hoyt","year":"2016","unstructured":"Hoyt AE, Borish L, Gurrola J, Payne S. Allergic fungal rhinosinusitis. J Allergy Clin Immunol Pract. 2016;4(4):599\u2013604.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"776_CR15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4193\/Rhin15.347","volume":"54","author":"MC Alanin","year":"2016","unstructured":"Alanin MC, Aanaes K, Hoiby N, Pressler T, Skov M, Nielsen KG, et al. Sinus surgery postpones chronic Gram-negative lung infection: cohort study of 106 patients with cystic fibrosis. Rhinology. 2016;54(3):206\u201313.","journal-title":"Rhinology"},{"issue":"3","key":"776_CR16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4193\/Rhin09.144","volume":"48","author":"JM Pinto","year":"2010","unstructured":"Pinto JM, Mehta N, DiTineo M, Wang J, Baroody FM, Naclerio RM. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010;48(3):318\u201324.","journal-title":"Rhinology"},{"issue":"1","key":"776_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","volume":"131","author":"P Gevaert","year":"2013","unstructured":"Gevaert P, Calus L, Van Zele T, Blomme K, De Ruyck N, Bauters W, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol. 2013;131(1):110\u20136.e1.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"776_CR18","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","volume":"140","author":"C Bachert","year":"2017","unstructured":"\u2022\u2022 Bachert C, Sousa AR, Lund VJ, Scadding GK, Gevaert P, Nasser S, et al. Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial. J Allergy Clin Immunol. 2017;140(4):1024\u201331.e14. COMMENT: Study showing that mepolizumab can reduce the need for surgery in severe CRSwNP.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"776_CR19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jaci.2006.05.031","volume":"118","author":"P Gevaert","year":"2006","unstructured":"Gevaert P, Lang-Loidolt D, Lackner A, Stammberger H, Staudinger H, Van Zele T, et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol. 2006;118(5):1133\u201341.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"776_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jama.2015.19330","volume":"315","author":"C Bachert","year":"2016","unstructured":"Bachert C, Mannent L, Naclerio RM, Mullol J, Ferguson BJ, Gevaert P, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016;315(5):469\u201379.","journal-title":"JAMA"},{"issue":"3","key":"776_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2500\/ajra.2012.26.3749","volume":"26","author":"T Nakayama","year":"2012","unstructured":"Nakayama T, Asaka D, Yoshikawa M, Okushi T, Matsuwaki Y, Moriyama H, et al. Identification of chronic rhinosinusitis phenotypes using cluster analysis. Am J Rhinol Allergy. 2012;26(3):172\u20136.","journal-title":"Am J Rhinol Allergy"},{"issue":"5","key":"776_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/alr.21496","volume":"5","author":"ZM Soler","year":"2015","unstructured":"Soler ZM, Hyer JM, Ramakrishnan V, Smith TL, Mace J, Rudmik L, et al. Identification of chronic rhinosinusitis phenotypes using cluster analysis. Int Forum Allergy Rhinol. 2015;5(5):399\u2013407.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"10","key":"776_CR23","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/all.12260","volume":"68","author":"ML Kowalski","year":"2013","unstructured":"Kowalski ML, Asero R, Bavbek S, Blanca M, Blanca-Lopez N, Bochenek G, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68(10):1219\u201332.","journal-title":"Allergy"},{"issue":"6","key":"776_CR24","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jaci.2013.02.036","volume":"131","author":"CA Akdis","year":"2013","unstructured":"Akdis CA, Bachert C, Cingi C, Dykewicz MS, Hellings PW, Naclerio RM, et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013;131(6):1479\u201390.","journal-title":"J Allergy Clin Immunol"},{"key":"776_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13601-017-0157-8","volume":"7","author":"G Greve De","year":"2017","unstructured":"\u2022\u2022 De Greve G, Hellings PW, Fokkens WJ, Pugin B, Steelant B, Seys SF. Endotype-driven treatment in chronic upper airway diseases. Clin Transl Allergy. 2017;7:22. COMMENT: Excellent overview of endotype-driven treatment in upper airway disease.","journal-title":"Clin Transl Allergy"},{"issue":"5","key":"776_CR26","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","volume":"137","author":"P Tomassen","year":"2016","unstructured":"Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449\u201356.e4.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"776_CR27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4193\/Rhin15.271","volume":"54","author":"H Lou","year":"2016","unstructured":"Lou H, Meng Y, Piao Y, Zhang N, Bachert C, Wang C, et al. Cellular phenotyping of chronic rhinosinusitis with nasal polyps. Rhinology. 2016;54(2):150\u20139.","journal-title":"Rhinology"},{"issue":"11","key":"776_CR28","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/j.1398-9995.2006.01225.x","volume":"61","author":"T Zele Van","year":"2006","unstructured":"Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61(11):1280\u20139.","journal-title":"Allergy"},{"issue":"3","key":"776_CR29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2500\/ajra.2014.28.4024","volume":"28","author":"S Vlaminck","year":"2014","unstructured":"Vlaminck S, Vauterin T, Hellings PW, Jorissen M, Acke F, Van Cauwenberge P, et al. The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis: a 3-year prospective observational study. Am J Rhinol Allergy. 2014;28(3):260\u20134.","journal-title":"Am J Rhinol Allergy"},{"issue":"4","key":"776_CR30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4193\/Rhin15.400","volume":"53","author":"A Muraro","year":"2015","unstructured":"Muraro A, Fokkens WJ, Pietikainen S, Borrelli D, Agache I, Bousquet J, et al. European symposium on precision medicine in allergy and airways diseases: report of the European Union parliament symposium (October 14, 2015). Rhinology. 2015;53(4):303\u20137.","journal-title":"Rhinology"},{"issue":"9","key":"776_CR31","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/all.13162","volume":"72","author":"PW Hellings","year":"2017","unstructured":"\u2022\u2022 Hellings PW, Fokkens WJ, Bachert C, Akdis CA, Bieber T, Agache I, et al. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis\u2014a EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017;72(9):1297\u2013305. COMMENT: Explanation of precision medicine in upper airway disease.","journal-title":"Allergy"},{"issue":"1","key":"776_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4193\/Rhin15.079","volume":"54","author":"V Pundir","year":"2016","unstructured":"Pundir V, Pundir J, Lancaster G, Baer S, Kirkland P, Cornet M, et al. Role of corticosteroids in functional endoscopic sinus surgery\u2014a systematic review and meta-analysis. Rhinology. 2016;54(1):3\u201319.","journal-title":"Rhinology"},{"key":"776_CR33","doi-asserted-by":"crossref","unstructured":"Fokkens WJ, Bachert C, Bernal-Sprekelsen M, Bousquet JEUFOREA. Rhinology future debates report. Rhinology. 2017;55(4)","DOI":"10.4193\/Rhin17.221"},{"key":"776_CR34","volume-title":"Rhinology","author":"PW Hellings","year":"2017","unstructured":"Hellings PW, Akdis CA, Bachert C, Bousquet J, Pugin B, Adriaensen G, et al. EUFOREA rhinology research forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis. In: Rhinology; 2017."},{"issue":"5","key":"776_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1398-9995.2010.02522.x","volume":"66","author":"J Bousquet","year":"2011","unstructured":"Bousquet J, Siergiejko Z, Swiebocka E, Humbert M, Rabe KF, Smith N, et al. Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma. Allergy. 2011;66(5):671\u20138.","journal-title":"Allergy"},{"issue":"2","key":"776_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1067\/mai.2001.117880","volume":"108","author":"W Busse","year":"2001","unstructured":"Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol. 2001;108(2):184\u201390.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"776_CR37","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1111\/cea.12400","volume":"44","author":"JP Arm","year":"2014","unstructured":"Arm JP, Bottoli I, Skerjanec A, Floch D, Groenewegen A, Maahs S, et al. Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects. Clin Exp Allergy: J Br Soc Allergy Clin Immunol. 2014;44(11):1371\u201385.","journal-title":"Clin Exp Allergy: J Br Soc Allergy Clin Immunol"},{"issue":"4","key":"776_CR38","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jaci.2016.02.027","volume":"138","author":"GM Gauvreau","year":"2016","unstructured":"Gauvreau GM, Arm JP, Boulet LP, Leigh R, Cockcroft DW, Davis BE, et al. Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses. J Allergy Clin Immunol. 2016;138(4):1051\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"243","key":"776_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008961","volume":"6","author":"GM Gauvreau","year":"2014","unstructured":"Gauvreau GM, Harris JM, Boulet LP, Scheerens H, Fitzgerald JM, Putnam WS, et al. Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production. Sci Transl Med. 2014;6(243):243ra85.","journal-title":"Sci Transl Med"},{"key":"776_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12931-016-0347-2","volume":"17","author":"JM Harris","year":"2016","unstructured":"Harris JM, Maciuca R, Bradley MS, Cabanski CR, Scheerens H, Lim J, et al. A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma. Respir Res. 2016;17:29.","journal-title":"Respir Res"},{"issue":"2","key":"776_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.alit.2014.12.006","volume":"64","author":"A Kato","year":"2015","unstructured":"Kato A. Immunopathology of chronic rhinosinusitis. Allergol Int: Off J Japan Soc Allergol. 2015;64(2):121\u201330.","journal-title":"Allergol Int: Off J Japan Soc Allergol"},{"issue":"7470","key":"776_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature12526","volume":"502","author":"JC Nussbaum","year":"2013","unstructured":"Nussbaum JC, Van Dyken SJ, von Moltke J, Cheng LE, Mohapatra A, Molofsky AB, et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature. 2013;502(7470):245\u20138.","journal-title":"Nature"},{"issue":"17","key":"776_CR43","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1517\/14656566.2013.837450","volume":"14","author":"GF Adriaensen","year":"2013","unstructured":"Adriaensen GF, Fokkens WJ. Chronic rhinosinusitis: an update on current pharmacotherapy. Expert Opin Pharmacother. 2013;14(17):2351\u201360.","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"776_CR44","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1164\/rccm.201103-0396OC","volume":"184","author":"M Castro","year":"2011","unstructured":"Castro M, Mathur S, Hargreave F, Boulet LP, Xie F, Young J, et al. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med. 2011;184(10):1125\u201332.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"776_CR45","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1513\/AnnalsATS.201312-454OC","volume":"11","author":"H Ortega","year":"2014","unstructured":"Ortega H, Li H, Suruki R, Albers F, Gordon D, Yancey S. Cluster analysis and characterization of response to mepolizumab. A step closer to personalized medicine for patients with severe asthma. Ann Am Thoracic Soc. 2014;11(7):1011\u20137.","journal-title":"Ann Am Thoracic Soc"},{"issue":"10056","key":"776_CR46","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","volume":"388","author":"ER Bleecker","year":"2016","unstructured":"Bleecker ER, FitzGerald JM, Chanez P, Papi A, Weinstein SF, Barker P, et al. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet (London, England). 2016;388(10056):2115\u201327.","journal-title":"Lancet (London, England)"},{"issue":"24","key":"776_CR47","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","volume":"375","author":"EL Simpson","year":"2016","unstructured":"Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375(24):2335\u201348.","journal-title":"N Engl J Med"},{"issue":"10013","key":"776_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(15)00388-8","volume":"387","author":"D Thaci","year":"2016","unstructured":"Thaci D, Simpson EL, Beck LA, Bieber T, Blauvelt A, Papp K, et al. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet (London, England). 2016;387(10013):40\u201352.","journal-title":"Lancet (London, England)."},{"issue":"10039","key":"776_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","volume":"388","author":"S Wenzel","year":"2016","unstructured":"Wenzel S, Castro M, Corren J, Maspero J, Wang L, Zhang B, et al. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet (London, England). 2016;388(10039):31\u201344.","journal-title":"Lancet (London, England)"},{"issue":"13","key":"776_CR50","first-page":"1276","volume":"369","author":"SE Wenzel","year":"2013","unstructured":"Wenzel SE, Wang L, Pirozzi G. Dupilumab in persistent asthma. N Engl J Med. 2013;369(13):1276.","journal-title":"N Engl J Med"},{"issue":"1","key":"776_CR51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/ACI.0000000000000234","volume":"16","author":"RP Schleimer","year":"2016","unstructured":"Schleimer RP, Schnaar RL, Bochner BS. Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression. Curr Opin Allergy Clin Immunol. 2016;16(1):24\u201330.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"776_CR52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000443930","volume":"168","author":"S Heck","year":"2015","unstructured":"Heck S, Nguyen J, Le DD, Bals R, Dinh QT. Pharmacological therapy of bronchial asthma: the role of biologicals. Int Arch Allergy Immunol. 2015;168(4):241\u201352.","journal-title":"Int Arch Allergy Immunol"},{"issue":"7","key":"776_CR53","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/j.1365-2222.2012.04014.x","volume":"42","author":"P Nair","year":"2012","unstructured":"Nair P, Gaga M, Zervas E, Alagha K, Hargreave FE, O'Byrne PM, et al. Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy: J Br Soc Allergy Clin Immunol. 2012;42(7):1097\u2013103.","journal-title":"Clin Exp Allergy: J Br Soc Allergy Clin Immunol"},{"issue":"10","key":"776_CR54","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S2213-2600(16)30227-2","volume":"4","author":"PM O'Byrne","year":"2016","unstructured":"O'Byrne PM, Metev H, Puu M, Richter K, Keen C, Uddin M, et al. Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2016;4(10):797\u2013806.","journal-title":"Lancet Respir Med"},{"issue":"11","key":"776_CR55","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","volume":"188","author":"WW Busse","year":"2013","unstructured":"Busse WW, Holgate S, Kerwin E, Chon Y, Feng J, Lin J, et al. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am J Respir Crit Care Med. 2013;188(11):1294\u2013302.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-018-0776-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-018-0776-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-018-0776-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T07:24:20Z","timestamp":1570951460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-018-0776-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,24]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["776"],"URL":"https:\/\/doi.org\/10.1007\/s11882-018-0776-8","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,24]]},"assertion":[{"value":"24 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"25"}}